Article Text
Statistics from Altmetric.com
A young woman presented with a 2-month history of progressive severe spastic paraparesis. An MR scan of spine showed a longitudinally-extensive myelopathy (figure 1). MR scan of the brain was normal. Cerebrospinal fluid showed elevated protein at 1.33 g/L, a normal white cell count, no malignant cells and normal glucose. An exhaustive biological blood screening was negative except for detection of antibodies targeting the M23 isoform on aquaporin-4 transfected cells.
MR scan of spine showing a longitudinally-extensive spinal cord lesion. (A) Sagittal T2 cervico thoracic cord MRI shows an extensive spindle-like hyperintense …
Footnotes
-
Contributors DB and RD: study design, drafting and revising the manuscript. CD and JS: data collection, critical comments during manuscript revision. KM: data collection, drafting and revising the manuscript. OG and RM: critical comments during manuscript revision.
-
Funding None.
-
Competing interests None.
-
Provenance and peer review Not commissioned; externally peer reviewed. This paper was reviewed by Jackie Palace, Oxford, UK, and Seth Love, Bristol, UK.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Linked Articles
- Editors' commentary
Read the full text or download the PDF:
Other content recommended for you
- Ring - enhancing spinal cord lesions in neuromyelitis optica spectrum disorders
- The borderland of neuromyelitis optica
- Neuromyelitis optica: an overview
- An elderly woman with leg weakness
- Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders
- Sera from neuromyelitis optica patients disrupt the blood – brain barrier
- A practical approach to the diagnosis of spinal cord lesions
- CSF high - mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica
- Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
- Expanding the range of immunopathology in neuromyelitis optica spectrum disorder